Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
Global Translational Regenerative Medicine Market to 2028 - Industry Analysis, Trends, Market Size and Forecasts - ResearchAndMarkets.com
By AP News - Oct 06, 2022, 08:30 AM ET
Last Updated - Jun 24, 2023, 03:47 AM EDT
DUBLIN--(BUSINESS WIRE)--Oct 6, 2022--
The "Translational Regenerative Medicine Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's offering.
The report on the global translational regenerative medicine market provides qualitative and quantitative analysis for the period from 2020 to 2028.
The report predicts the global translational regenerative medicine market to grow with a CAGR of 11% over the forecast period from 2022-2028. The study on translational regenerative medicine market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2020 to 2028.
The report on translational regenerative medicine market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global translational regenerative medicine market over the period of 2020 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global translational regenerative medicine market over the period of 2020 to 2028. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Market Dynamics
Drivers
- Growing awareness in people about regenerative medicine
- Growing accessibility to healthcare
Restraints
- High cost associated with research and development
Opportunities
- Growing investments in R&D of new regenerative diseases
Segment Covered
The global translational regenerative medicine market is segmented on the basis of product type, and application.
The Global Translational Regenerative Medicine Market by Product Type
- Tissue Engineered Products
- Cell Based Products
- Gene Therapy Products
The Global Translational Regenerative Medicine Market by Application
- Orthopedic
- Dermatology
- Cardiovascular
- Neurology
- Oncology
- Diabetes
- Others
Company Profiles
The companies covered in the report include
- Anika Therapeutics
- Nuvasive, Inc.
- Orthofix International N.V
- Medipost
- Athersys, Inc.
- Celgene Corporation
- Vericel Corporation
- Novartis
- Brainstorm Cell Therapeutics Inc.
- Gamida Cell Ltd.
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the translational regenerative medicine market.
2. Complete coverage of all the segments in the translational regenerative medicine market to analyze the trends, developments in the global market and forecast of market size up to 2028.
3. Comprehensive analysis of the companies operating in the global translational regenerative medicine market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
For more information about this report visit https://www.researchandmarkets.com/r/wx4r7u
View source version on businesswire.com:https://www.businesswire.com/news/home/20221006005585/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: DIABETES PHARMACEUTICAL HEALTH
Sponsored
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 10/06/2022 08:27 AM/DISC: 10/06/2022 08:27 AM
http://www.businesswire.com/news/home/20221006005585/en
Sponsored
Popular News
Latest News